Traveling with peptides: TSA, customs and keeping vials cold

Every compound page gives the same storage pattern: lyophilized powder in the freezer or fridge away from light, stable for months, and reconstituted solution in the fridge at 2 to 8 C, used within four weeks. The powder is the travel form. Vendors ship it at ambient temperature as a matter of routine, and a few days in a bag at room temperature does not meaningfully change it. The plan that avoids most problems is sealed powder vials plus a sealed vial of bacteriostatic water, mixed at the destination. The reconstitution guide covers the mixing, and bacteriostatic water vs sterile water explains the water choice.

Some things are already liquid. Branded GLP-1 pens, Lilly's single dose tirzepatide vials and compounded semaglutide or tirzepatide all travel as solutions and need the cold chain below, and the semaglutide page is explicit that a mixed vial should not be frozen. NAD+ is the fussiest common compound: it degrades in solution faster than peptides, has a two to four week window once mixed, and is discarded if it turns yellow or cloudy.

A trip's worth plus a small margin means fewer vials to keep cold and fewer questions at a checkpoint; how long do peptides last covers the storage windows in detail.

An insulated medication case with two gel packs holds a reconstituted vial in the 2 to 8 C range for a travel day of eight to twelve hours, longer if pre-chilled. The mistake is putting a vial directly against a frozen pack. A vial touching a frozen pack can freeze solid, which the compound pages say to avoid and which, for semaglutide, means discard. A cloth wrap or the case's divider is enough.

At the destination, the hotel minifridge is a gamble: many run warm, and some freeze whatever sits at the back near the cooling element. A cheap fridge thermometer settles it, and the middle shelf or door is safer than the back wall. Cars are the other failure point; a closed car in summer sun can pass 50 C inside within an hour, so on a road trip the case rides in the cabin. Checked baggage holds vary and bags sit on hot tarmac, so vials travel in the carry-on.

TSA's published policy, as of this writing, is that medications in pill, liquid or injectable form are allowed in carry-on and checked bags. Liquid medication is exempt from the 3.4 oz or 100 mL limit in reasonable quantities when it is medically necessary and declared at the checkpoint. Unused syringes are allowed when accompanied by injectable medication. Gel packs are allowed frozen, and partially melted when keeping medication cold. TSA states that it does not require medication in its original container or a prescription, while noting that some states have their own labeling laws. Officers have discretion on all of it.

In practice: declare the medication bag, keep vials and syringes together in a clear pouch, and carry a prescriber's letter if one exists, which it will for a GLP-1 pen and will not for a research peptide. TSA screens for security threats rather than drugs, and research peptides are unapproved rather than controlled substances in the US, which is why domestic flights with them are routine. A small hard sharps container handles used needles.

Semaglutide and tirzepatide pens are labeled prescription medicines, which makes them easier at security and at borders than any research vial, as long as they stay in the original box with the pharmacy label. Each has a published room temperature window once it leaves the fridge: tirzepatide pens and vials may sit at room temperature for up to 21 days, and the semaglutide leaflet gives a window of a few weeks depending on the product. The clock does not stop by putting the pen back in the fridge, so a two week trip needs no cooling and a long stay needs a fridge. Rybelsus tablets have no cold chain at all.

For international travel the usual pattern is a copy of the prescription, the original packaging and an obviously personal quantity, which most countries accept for approved medicines within a limit commonly around a 90 day supply. Weekly dosing makes time zones simple, because the day matters and the hour does not, and the missed dose windows on the compound pages, up to five days late for semaglutide and within four days for tirzepatide, cover most disruptions.

Domestic flights are a TSA question. Crossing a border is a customs question under the destination's drug law, and the personal medication exemption that covers an approved pen does not cover BPC-157, TB-500, melanotan-2 or anything else that is not a medicine anywhere. The common outcome when such vials are found is seizure with a notice, sometimes a fine. A few countries go further. Australia treats peptides as prescription-only, Border Force seizes imports without a prescription, and melanotan products are a known target. Returning to the US, customs can seize unapproved drugs, and FDA's personal importation policy is discretionary rather than a right.

The compounds that invite the most questions are the ones that look like drugs to an inspector. Melanotan vials and nasal tanning sprays have drawn specific UK and Australian regulator warnings. Semax and Selank are Russian prescription products approved there and nowhere else. A research use only label does nothing at a border; it describes how the vendor sold it, not whether import is legal. The practical hedge is small quantities, original packaging, honesty if asked, and the knowledge that a research peptide may not come back out of the inspection room.

First, define warm. A reconstituted vial that spent a few hours at ordinary room temperature is almost certainly fine. Peptides lose potency gradually, not all at once, and the four week fridge window on the compound pages is conservative. A full day in a hot car above 35 C is a different event: expect meaningful potency loss, though the vial has not become dangerous unless something is growing in it, which bacteriostatic water is there to prevent.

The signals to discard are visual. Cloudiness, particles, a color change such as GHK-Cu losing its blue or NAD+ turning yellow, or any smell from the vial mean it goes in the bin. A clear solution that looks as it did is probably weaker at worst. Compensating for suspected potency loss with a bigger dose is guesswork; the choice is the usual dose with a possibly smaller effect, or a replacement if the compound is cheap. For a GLP-1 pen that exceeded its labeled window, the label answer is to discard and the pharmacy can advise on a replacement.

The night before: freeze the gel packs and chill the case. The morning of: pack powder vials, sealed bacteriostatic water, more insulin syringes than the trip needs, a mixing syringe, swabs, the wrapped packs, a small sharps container, any prescription or letter, and a printout of the TSA medication page. At the destination: into a fridge within a few hours, with a thermometer if the fridge is unknown. On return: discard any reconstituted vial that exceeded its window, and revisit peptide injection sites if a cramped hotel bathroom made rotation lazy.

Driving changes only the cooling problem: a cooler in the cabin rather than the trunk, and no vial left in a parked car. Long stays mean a fridge for the mixed vial and powder for the rest, and how to buy peptides covers resupply.